CD9 and acute myeloid leukemia: MRP-1 proteins could be delivered from chemo-resistance HL-60 cells to chemo-sensitive leukemic cells. Circulating EVs containing miR-19b and miR-20a are responsible for the induction of chemo-resistance in AML patients and thereby reduce their overall survival.